Voloridge Investment Management, LLC Alector, Inc. Transaction History

Voloridge Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $3.01 Million - $4.8 Million	-230,867 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $3.77 Million - $4.98 Million	-195,035 Reduced 45.79%	230,867 $4.77 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $6.9 Million - $12.6 Million	318,605 Added 296.94%	425,902 $9.72 Million
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $1.66 Million - $2.41 Million	107,297 New	107,297 $2.24 Million
Q4 2020 Feb 16, 2021	SELL	$9.4 - $16.7 $206,189 - $366,314	-21,935 Closed	0 $0

Q3 2020 Nov 16, 2020	BUY	$10.54 - $24.96 $231,194 - $547,497	21,935 New	21,935 $231,000
Q2 2020 Aug 14, 2020	SELL	$21.87 - $33.11 $316,043 - $478,472	-14,451 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.25 - $35.28 $226,053 - $490,780	-13,911 Reduced 49.05%	14,451 $349,000
Q4 2019 Feb 14, 2020	BUY	$14.17 - $20.3 $401,889 - $575,748	28,362 New	28,362 $489,000

161

59.8M

67.8K

200

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $358M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.